MicroRNAs (miRNAs) regulate gene expression. It has been suggested that obtaining miRNA expression profiles can improve classification, diagnostic, and prognostic information in oncology. Here, we sought to comprehensively identify the miRNAs that are overexpressed in lung cancer by conducting miRNA microarray expression profiling on normal lung versus adjacent lung cancers from transgenic mice. We found that miR-136, miR-376a, and miR-31 were each prominently overexpressed in murine lung cancers. Real-time RT-PCR and in situ hybridization (ISH) assays confirmed these miRNA expression profiles in paired normal-malignant lung tissues from mice and humans. Engineered knockdown of miR-31, but not other highlighted miRNAs, substantially repressed lung cancer cell growth and tumorigenicity in a dose-dependent manner. Using a bioinformatics approach, we identified miR-31 target mRNAs and independently confirmed them as direct targets in human and mouse lung cancer cell lines. These targets included the tumor-suppressive genes large tumor suppressor 2 (LATS2) and PP2A regulatory subunit B alpha isoform (PPP2R2A), and expression of each was augmented by miR-31 knockdown. Their engineered repression antagonized miR-31–mediated growth inhibition. Notably, miR-31 and these target mRNAs were inversely expressed in mouse and human lung cancers, underscoring their biologic relevance. The clinical relevance of miR-31 expression was further independently and comprehensively validated using an array containing normal and malignant human lung tissues. Together, these findings revealed that miR-31 acts as an oncogenic miRNA (oncomir) in lung cancer by targeting specific tumor suppressors for repression.
Xi Liu, Lorenzo F. Sempere, Haoxu Ouyang, Vincent A. Memoli, Angeline S. Andrew, Yue Luo, Eugene Demidenko, Murray Korc, Wei Shi, Meir Preis, Konstantin H. Dragnev, Hua Li, James DiRenzo, Mads Bak, Sarah J. Freemantle, Sakari Kauppinen, Ethan Dmitrovsky
Title and authors | Publication | Year |
---|---|---|
CDK2 inhibition produces a persistent population of polyploid cancer cells with a survival advantage
Liliya Tyutyunyk-Massey, Zibo Chen, Xiuxia Liu, Masanori Kawakami, Adam Harned, Yeap Ng, Brian Luke, Samuel Okpechi, Blessing Ogunlade, Yair Alfaro, Roberto Weigert, Kedar Narayan, Xi Liu, Ethan Dmitrovsky |
JCI insight | 2025 |
The Role of microRNAs in Lung Cancer: Mechanisms, Diagnostics and Therapeutic Potential
Bartoszewska E, Misiąg P, Czapla M, Rakoczy K, Tomecka P, Filipski M, Wawrzyniak-Dzierżek E, Choromańska A |
International Journal of Molecular Sciences | 2025 |
Current Evidence Supporting the Role of miRNA as a Biomarker for Lung Cancer Diagnosis Through Exhaled Breath Condensate Collection: A Narrative Review
Ferrari PA, Salis CB, Macciò A |
Life | 2025 |
microRNAs in exhaled breath condensate for diagnosis of lung cancer in a resource-limited setting: a concise review.
Rai D, Pattnaik B, Bangaru S, Tak J, Kumari J, Verma U, Vadala R, Yadav G, Dhaliwal RS, Kumar S, Kumar R, Jain D, Luthra K, Chosdol K, Palanichamy JK, Khan MA, Surendranath A, Mittal S, Tiwari P, Hadda V, Madan K, Agrawal A, Guleria R, Mohan A |
2024 | |
Interaction of noncoding RNAs with hippo signaling pathway in cancer cells and cancer stem cells
Abedimanesh S, Safaralizadeh R, Jahanafrooz Z, Najafi S, Amini M, Nazarloo SS, Bahojb Mahdavi SZ, Baradaran B, Jebelli A, Mokhtarzadeh AA |
Non-coding RNA Research | 2024 |
Initial development and testing of an exhaled microRNA detection strategy for lung cancer case–control discrimination
Shi M, Han W, Loudig O, Shah CD, Dobkin JB, Keller S, Sadoughi A, Zhu C, Siegel RE, Fernandez MK, DeLaRosa L, Patel D, Desai A, Siddiqui T, Gombar S, Suh Y, Wang T, Hosgood HD, Pradhan K, Ye K, Spivack SD |
Scientific Reports | 2023 |
miR-31 ameliorates type 2 diabetic vascular damage through up-regulation of hypoxia-inducible factor-1α/vascular endothelial growth factor-A.
Fu Y, Du R, Wang Y, Yuan Y, Zhang Y, Wang C, Zhang X |
Journal of Diabetes Investigation | 2023 |
A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment.
Wei CH, Huang L, Kreh B, Liu X, Tyutyunyk-Massey L, Kawakami M, Chen Z, Shi M, Kozlov S, Chan KC, Andresson T, Carrington M, Vuligonda V, Sanders ME, Horowitz A, Hwu P, Peng W, Dmitrovsky E, Liu X |
Scientific Reports | 2023 |
CDK2 inhibition disorders centrosome stoichiometry and alters cellular outcomes in aneuploid cancer cells
Chen Z, Liu X, Kawakami M, Liu X, Baker A, Bhatawadekar A, Tyutyunyk-Massey L, Narayan K, Dmitrovsky E |
Cancer biology & therapy | 2023 |
Role of MicroRNA-31 (miR-31) in Breast Carcinoma Diagnosis and Prognosis
GHARIB AF, KHALIFA AS, EED EM, BANJER HJ, SHAMI AA, EL ASKARY A, ELSAWY WH |
In vivo (Athens, Greece) | 2022 |
Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer.
Chu J, Fang X, Sun Z, Gai L, Dai W, Li H, Yan X, Du J, Zhang L, Zhao L, Xu D, Yan S |
Frontiers in Oncology | 2022 |
Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis.
Chen Z, Zheng L, Chen Y, Liu X, Kawakami M, Mustachio LM, Roszik J, Ferry-Galow KV, Parchment RE, Liu X, Andresson T, Duncan G, Kurie JM, Rodriguez-Canales J, Liu X, Dmitrovsky E |
Cancer biology & therapy | 2022 |
MicroRNA Expression in Plasma of Esophageal Squamous Cell Carcinoma Patients
Kahng DH, Kim GH, Park SJ, Kim S, Lee MW, Lee BE, I H |
Journal of Korean Medical Science | 2022 |
Small Nucleolar Derived RNAs as Regulators of Human Cancer
Coley AB, DeMeis JD, Chaudhary NY, Borchert GM |
Biomedicines | 2022 |
The spring-like effect of microRNA-31 in balancing inflammatory and regenerative responses in colitis
Qu J, Shao C, Ying Y, Wu Y, Liu W, Tian Y, Yin Z, Li X, Yu Z, Shuai J |
Frontiers in microbiology | 2022 |
MiR-196a-5p facilitates progression of estrogen-dependent endometrial cancer by regulating FOXO1.
Zhu Y, Tang Y, Fan Y, Wu D |
Histology and histopathology | 2022 |
miR-31 Displays Subtype Specificity in Lung Cancer
ML Davenport, JB Echols, AD Silva, JC Anderson, P Owens, C Yates, Q Wei, S Harada, DR Hurst, MD Edmonds |
Cancer research | 2021 |
YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance
F Szulzewsky, EC Holland, V Vasioukhin |
Developmental Biology | 2021 |
The high expression of miR-31 in lung adenocarcinoma inhibits the malignancy of lung adenocarcinoma tumor stem cells
Xu R, Liu T, Zuo L, Guo D, Ye G, Jiang J, Yu X, Zhang S, Hou C |
Biochemistry and Biophysics Reports | 2021 |
MicroRNA Profile for Diagnostic and Prognostic Biomarkers in Thyroid Cancer.
Park JL, Kim SK, Jeon S, Jung CK, Kim YS |
Cancers | 2021 |
A Novel CDK2/9 Inhibitor CYC065 Causes Anaphase Catastrophe and Represses Proliferation, Tumorigenesis, and Metastasis in Aneuploid Cancers
M Kawakami, LM Mustachio, Y Chen, Z Chen, X Liu, CH Wei, J Roszik, AS Kittai, AV Danilov, X Zhang, B Fang, J Wang, JV Heymach, L Tyutyunyk-Massey, SJ Freemantle, JM Kurie, , E Dmitrovsky |
Molecular cancer therapeutics | 2020 |
Non-Coding RNAs as Prognostic Biomarkers: A miRNA Signature Specific for Aggressive Early-Stage Lung Adenocarcinomas
E Dama, V Melocchi, F Mazzarelli, T Colangelo, R Cuttano, LD Candia, GM Ferretti, M Taurchini, P Graziano, F Bianchi |
Non-Coding RNA | 2020 |
MiRNAs and LncRNAs: Dual Roles in TGF-β Signaling-Regulated Metastasis in Lung Cancer
XN Lai, J Li, LB Tang, WT Chen, L Zhang, LX Xiong |
International journal of molecular sciences | 2020 |
Salivary Biomarkers for Diagnosis of Inflammatory Bowel Diseases: A Systematic Review
K Nijakowski, A Surdacka |
International journal of molecular sciences | 2020 |
Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future
G Reid, TG Johnson, N van Zandwijk |
Frontiers in Oncology | 2020 |
Tissue microRNAs in non-small cell lung cancer detected with a new kind of liquid bead array detection system
YY Zheng, Y Fei, Z Wang, Y Chen, C Qiu, FR Li |
Journal of Translational Medicine | 2020 |
Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer
X Jin, Y Guan, Z Zhang, H Wang |
BMC Cancer | 2020 |
MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions
AM ElKhouly, RA Youness, MZ Gad |
Non-coding RNA Research | 2020 |
Dynamical network analysis reveals key microRNAs in progressive stages of lung cancer
C Kong, YX Yao, ZT Bing, BH Guo, L Huang, ZG Huang, YC Lai, I Ioshikhes |
PLoS computational biology | 2020 |
circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway
QS Peng, YN Cheng, WB Zhang, H Fan, QH Mao, P Xu |
Cell Death and Disease | 2020 |
miR-331-3p Inhibits Tumor Cell Proliferation, Metastasis, Invasion by Targeting MLLT10 in Non-Small Cell Lung Cancer QQ Tian, J Xia, X Zhang, BQ Gao, W Wang |
Cancer management and research | 2020 |
Unravelling the Role of miR-20b-5p, CCNB1, HMGA2 and E2F7 in Development and Progression of Non-Small Cell Lung Cancer (NSCLC)
S Arora, P Singh, AH Rahmani, SA Almatroodi, R Dohare, MA Syed |
Biology : open access journal | 2020 |
Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice
H Yamashita, S Surapureddi, RC Kovi, S Bhusari, TV Ton, JL Li, KR Shockley, SD Peddada, KE Gerrish, CV Rider, MJ Hoenerhoff, RC Sills, AR Pandiri |
Archives of Toxicology | 2020 |
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer Growth
, Y Lu, Z Chen, X Liu, W Hu, L Zheng, Y Chen, JM Kurie, M Shi, LM Mustachio, T Adresson, S Fox, J Roszik, M Kawakami, SJ Freemantle, E Dmitrovsky |
Molecular cancer research : MCR | 2020 |
MicroRNAs: Crucial Regulators of Stress
Roufayel R, Kadry S |
2020 | |
MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma
N García-Sancha, R Corchado-Cobos, J Pérez-Losada, J Cañueto |
International journal of molecular sciences | 2019 |
miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer
Z Lu, Q He, J Liang, W Li, Q Su, Z Chen, Q Wan, X Zhou, L Cao, J Sun, Y Wu, L Liu, X Wu, J Hou, K Lian, A Wang |
Molecular Therapy — Nucleic Acids | 2019 |
MiR-222-3p in Platelets Serves as a Distinguishing Marker for Early Recognition of Kawasaki Disease
B Wang, L Wang, F Cheng, H Lv, L Sun, D Wei, Y Pu, J Wu, Y Hou, B Wen, X Xu, W Yan |
Frontiers in Pediatrics | 2019 |
FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer
HH Hsu, WW Kuo, HN Shih, SF Cheng, CK Yang, MC Chen, CC Tu, VP Viswanadha, PH Liao, CY Huang |
Cancers | 2019 |
Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer
Q Wang, T Xu, Y Tong, J Wu, W Zhu, Z Lu, J Ying |
Molecular Therapy — Nucleic Acids | 2019 |
MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2
YH Lai, H Liu, WF Chiang, TW Chen, LJ Chu, JS Yu, SJ Chen, HC Chen, BC Tan |
Theranostics | 2018 |
Evidence for a radiation-responsive ‘p53 gateway’ contributing significantly to the radioresistance of lepidopteran insect cells
A Kumar, S Chandna |
Scientific Reports | 2018 |
Tissue and serum microRNA profile of oral squamous cell carcinoma patients
A Schneider, B Victoria, YN Lopez, W Suchorska, W Barczak, A Sobecka, W Golusinski, MM Masternak, P Golusinski |
Scientific Reports | 2018 |
Polo-like kinase 4 inhibition produces polyploidy and apoptotic death of lung cancers
M Kawakami, LM Mustachio, L Zheng, Y Chen, J Rodriguez-Canales, B Mino, JM Kurie, J Roszik, PA Villalobos, KL Thu, J Silvester, DW Cescon, II Wistuba, TW Mak, , E Dmitrovsky |
Proceedings of the National Academy of Sciences | 2018 |
miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2
P Ma, K Ni, J Ke, W Zhang, Y Feng, Q Mao |
Experimental biology and medicine (Maywood, N.J.) | 2018 |
Modulation of oncogenic miRNA biogenesis using functionalized polyamines
C Staedel, TP Tran, J Giraud, F Darfeuille, AD Giorgio, NJ Tourasse, F Salin, P Uriac, M Duca |
Scientific Reports | 2018 |
Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
J Yue, D Lv, C Wang, L Li, Q Zhao, H Chen, L Xu |
Oncogene | 2018 |
MicroRNAs and their role in environmental chemical carcinogenesis
M Li, X Huo, CB Davuljigari, Q Dai, X Xu |
Environmental Geochemistry and Health | 2018 |
miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2
Z Mohamed, MK Hassan, S Okasha, T Mitamura, S Keshk, Y Konno, T Kato, SF EL-khamisy, Y Ohba, H Watari |
Oncotarget | 2018 |
MiR-1256 suppresses proliferation and migration of non-small cell lung cancer via regulating TCTN1
W Liu, X Wan, Z Mu, F Li, L Wang, J Zhao, X Huang |
Oncology Letters | 2018 |
Is microRNA-31 a key regulator of breast tumorigenesis?
T Powrózek, T Małecka-Massalska |
Journal of Thoracic Disease | 2018 |
Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression
J Zhang, D Gao, H Zhang |
Molecular medicine reports | 2018 |
Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma
T He, K McColl, N Sakre, Y Chen, G Wildey, A Dowlati |
Molecular Oncology | 2018 |
Large tumor suppressor 2, LATS2, activates JNK in a kinase-independent mechanism through ASK1
L Rusnak, C Tang, Q Qi, X Mo, H Fu, J Wu |
Journal of Molecular Cell Biology | 2018 |
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer
LM Mustachio, Y Lu, LJ Tafe, V Memoli, J Rodriguez-Canales, B Mino, PA Villalobos, I Wistuba, H Katayama, SM Hanash, J Roszik, M Kawakami, K Cho, JF Hancock, F Chinyengetere, S Hu, X Liu, SJ Freemantle, E Dmitrovsky |
Molecular cancer research : MCR | 2017 |
Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection
C Stenfeldt, J Arzt, G Smoliga, M LaRocco, J Gutkoska, P Lawrence |
Virology Journal | 2017 |
Expression of miR-23a by Apoptotic Regulators in Human Cancer: A Review
R Roufayel, S Kadry |
Cancer biology & therapy | 2017 |
The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection
HF Moffett, AN Cartwright, HJ Kim, J Godec, J Pyrdol, T Äijö, GJ Martinez, A Rao, J Lu, TR Golub, H Cantor, AH Sharpe, CD Novina, KW Wucherpfennig |
Nature Immunology | 2017 |
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
N Furth, Y Aylon |
Cell Death and Differentiation | 2017 |
Identification of aminosulfonylarylisoxazole as microRNA-31 regulators
K Im, J Song, YT Han, S Lee, S Kang, KW Hwang, H Min, KH Min, BB Yang |
PloS one | 2017 |
MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells
A Korourian, R Roudi, A Shariftabrizi, Z Madjd |
Experimental biology and medicine (Maywood, N.J.) | 2017 |
Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles
SY Sathipati, SY Ho |
Scientific Reports | 2017 |
MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis
Y Yang, L Ding, Q Hu, J Xia, J Sun, X Wang, H Xiong, D Gurbani, L Li, Y Liu, A Liu |
Molecular Cancer | 2017 |
miR-31 Functions as an Oncomir Which Promotes Epithelial-Mesenchymal Transition via Regulating BAP1 in Cervical Cancer
N Wang, Y Li, J Zhou |
BioMed Research International | 2017 |
MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists
C Lv, F Li, X Li, Y Tian, Y Zhang, X Sheng, Y Song, Q Meng, S Yuan, L Luan, T Andl, X Feng, B Jiao, M Xu, MV Plikus, X Dai, C Lengner, W Cui, F Ren, J Shuai, SE Millar, Z Yu |
Nature Communications | 2017 |
Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study
L Izquierdo, R Montalbo, M Ingelmo-Torres, C Mallofré, M Ramírez-Backhaus, J Rubio, AV der Heijden, E Schaafsma, A Lopez-Beltran, A Blanca, N Lawrentschuk, A Alcaraz, L Mengual |
Oncotarget | 2017 |
MicroRNA‑31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1
N Lin, Y Zhou, X Lian, Y Tu |
Oncology Letters | 2017 |
Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance
C Li, Y Yin, X Liu, X Xi, W Xue, Y Qu |
Oncotarget | 2017 |
Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma
Y Gao, J Yi, K Zhang, F Bai, B Feng, R Wang, X Chu, L Chen, H Song |
Journal of Experimental & Clinical Cancer Research | 2017 |
MicroRNA-31 suppresses the self-renewal capability of α2δ1+ liver tumor-initiating cells by targeting ISL1
Y Zhang, W Zhao, H Han, S Li, D Chen, Z Zhang |
Oncotarget | 2017 |
MicroRNA-31 promotes arterial smooth muscle cell proliferation and migration by targeting mitofusin‑2 in arteriosclerosis obliterans of the lower extremitie
S Huang, Z Chen, W Wu, M Wang, R Wang, J Cui, W Li, S Wang |
Experimental and therapeutic medicine | 2017 |
LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer
S Matsui, N Kagara, C Mishima, Y Naoi, M Shimoda, A Shimomura, K Shimazu, S Kim, S Noguchi |
Oncology Letters | 2017 |
miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition
H Ren, Y Qi, X Yin, J Gao |
OncoTargets and therapy | 2017 |
Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer
M Kawakami, LM Mustachio, J Rodriguez-Canales, B Mino, J Roszik, P Tong, J Wang, JJ Lee, JH Myung, JV Heymach, FM Johnson, S Hong, L Zheng, S Hu, PA Villalobos, C Behrens, I Wistuba, S Freemantle, , E Dmitrovsky |
JNCI Journal of the National Cancer Institute | 2017 |
Function and regulation of microRNA-31 in development and disease: miR-31 IN D EVELOPMENT AND D ISEASE
NA Stepicheva, JL Song |
Molecular Reproduction and Development | 2016 |
The roles of miRNAs as potential biomarkers in lung diseases
SD Alipoor, IM Adcock, J Garssen, E Mortaz, M Varahram, M Mirsaeidi, A Velayati |
European Journal of Pharmacology | 2016 |
MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer
C Caramés, I Cristobal, V Moreno, J Marín, P González-Alonso, B Torrejón, P Minguez, A Leon, J Martín, R Hernández, M Pedregal, M Martín, D Cortés, D García-Olmo, M Fernández, F Rojo, J García-Foncillas |
International journal of molecular sciences | 2016 |
Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D
T Zhang, Y Hu, J Ju, L Hou, Z Li, D Xiao, Y Li, J Yao, C Wang, Y Zhang, L Zhang |
Scientific Reports | 2016 |
miR-19a/b modulates lung cancer cells metastasis through suppression of MXD1 expression
W Hu, P Jin, C Ding, W Liu |
Oncology Letters | 2016 |
miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer
M Yan, X Li, D Tong, C Han, R Zhao, Y He, X Jin |
Oncology reports | 2016 |
Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1
OA Kent, JT Mendell, R Rottapel |
Molecular cancer research : MCR | 2016 |
Regulatory mechanisms of microRNAs in lung cancer stem cells
T Fan, W Wang, B Zhang, Y Xu, L Chen, S Pan, H Hu, Q Geng |
SpringerPlus | 2016 |
The ISG15-specific protease USP18 regulates stability of PTEN
LM Mustachio, M Kawakami, Y Lu, J Rodriguez-Canales, B Mino, C Behrens, I Wistuba, N Bota-Rabassedas, J Yu, JJ Lee, J Roszik, L Zheng, X Liu, SJ Freemantle, E Dmitrovsky |
Oncotarget | 2016 |
In Silico Study of miRNA Based Gene Regulation, Involved in Solid Cancer, by the Assistance of Argonaute Protein
SN Rath, D Das, VB Konkimalla, SK Pradhan |
Genomics & Informatics | 2016 |
Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2
H Wang, X Zhang, Y Liu, Z Ni, Y Lin, Z Duan, Y Shi, G Wang, F Li |
Oncotarget | 2016 |
BAP1 suppresses lung cancer progression and is inhibited by miR-31
Yu M, Liang H, Fu Z, Wang X, Liao Z, Zhou Y, Liu Y, Wang Y, Hong Y, Zhou X, Yan X, Yu M, Ma M, Zhang W, Guo B, Zhang J, Zen K, Zhang CY, Wang T, Zhang Q, Chen X |
Oncotarget | 2016 |
miR-31 initiates lung tumorigenesis and promotes mutant KRas-driven lung cancer
Mick Edmonds, Kelli L. Boyd, Tamara Moyo, Ramkrishna Mitra, Robert Duszynski, Maria Arrate, Xi Chen, Zhongming Zhao, Timothy Blackwell, Thomas andl, Christine Eischen |
Journal of Clinical Investigation | 2015 |
Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma
PN Valdmanis, B Roy-Chaudhuri, HK Kim, LC Sayles, Y Zheng, CH Chuang, DR Caswell, K Chu, Y Zhang, MM Winslow, EA Sweet-Cordero, MA Kay |
Oncogene | 2015 |
Advances in Experimental Medicine and Biology
G Santulli |
Advances in experimental medicine and biology | 2015 |
MicroRNA-31 Is a Transcriptional Target of Histone Deacetylase Inhibitors and a Regulator of Cellular Senescence
JH Cho, M Dimri, GP Dimri |
The Journal of biological chemistry | 2015 |
The Interplay between PP2A and microRNAs in Leukemia
PP Ruvolo |
Frontiers in Oncology | 2015 |
From the Biology of PP2A to the PADs for Therapy of Hematologic Malignancies
M Ciccone, GA Calin, D Perrotti |
Frontiers in Oncology | 2015 |
Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration
T Mikami, S Maruyama, T Abé, T Kobayashi, M Yamazaki, A Funayama, S Shingaki, T Kobayashi, C Jun, T Saku |
Virchows Archiv | 2015 |
SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells
RB Koumangoye, T Andl, KJ Taubenslag, ST Zilberman, CJ Taylor, HA Loomans, CD Andl |
Molecular Cancer | 2015 |
MicroRNA signatures differentiate Crohn’s disease from ulcerative colitis
JS Schaefer, T Attumi, AR Opekun, B Abraham, J Hou, H Shelby, DY Graham, C Streckfus, JR Klein |
BMC Immunology | 2015 |
Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence: miR-34a and Bladder Cancer Recurrence
AS Andrew, CJ Marsit, AR Schned, JD Seigne, KT Kelsey, JH Moore, L Perreard, MR Karagas, LF Sempere |
International Journal of Cancer | 2015 |
Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer
X Bian, Y Shen, G Zhang, C Gu, Y Cai, C Wang, Y Zhu, Y Zhu, H Zhang, B Dai, D Ye, AP Singh |
PloS one | 2015 |
Expression and Significance of Circulating MicroRNA-31 in Lung Cancer Patients
W Gu |
Medical science monitor : international medical journal of experimental and clinical research | 2015 |
Differentially Expressed MicroRNAs in Postpartum Breast Cancer in Hispanic Women
JL Muñoz-Rodríguez, L Vrba, BW Futscher, C Hu, IK Komenaka, MM Meza-Montenegro, LE Gutierrez-Millan, A Daneri-Navarro, PA Thompson, ME Martinez, DR Carter |
PloS one | 2015 |
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
T Higashi, H Hayashi, T Ishimoto, H Takeyama, T Kaida, K Arima, K Taki, K Sakamoto, H Kuroki, H Okabe, H Nitta, D Hashimoto, A Chikamoto, T Beppu, H Baba |
British Journal of Cancer | 2015 |
MicroRNA: master controllers of intracellular signaling pathways
PY Lui, DY Jin, NJ Stevenson |
Cellular and Molecular Life Sciences | 2015 |
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
F Skoulidis, LA Byers, L Diao, VA Papadimitrakopoulou, P Tong, J Izzo, C Behrens, H Kadara, ER Parra, JR Canales, J Zhang, U Giri, J Gudikote, MA Cortez, C Yang, Y Fan, M Peyton, L Girard, KR Coombes, C Toniatti, TP Heffernan, M Choi, GM Frampton, V Miller, JN Weinstein, RS Herbst, KK Wong, J Zhang, P Sharma, GB Mills, WK Hong, JD Minna, JP Allison, A Futreal, J Wang, II Wistuba, JV Heymach |
Cancer Discovery | 2015 |
Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo
C Taccioli, M Garofalo, H Chen, Y Jiang, GM Tagliazucchi, GD Leva, H Alder, P Fadda, J Middleton, KJ Smalley, T Selmi, S Naidu, JL Farber, CM Croce, LY Fong |
JNCI Journal of the National Cancer Institute | 2015 |
Effective Capture of Circulating Tumor Cells from a Transgenic Mouse Lung Cancer Model using Dendrimer Surfaces Immobilized with anti-EGFR
JH Myung, M Roengvoraphoj, KA Tam, T Ma, VA Memoli, E Dmitrovsky, SJ Freemantle, S Hong |
Analytical Chemistry | 2015 |
Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells
P Samuel, RC Pink, DP Caley, JM Currie, SA Brooks, DR Carter |
Tumor Biology | 2015 |
MicroRNAs in mesothelioma: From tumour suppressors and biomarkers to therapeutic targets
Glen Reid, Glen Reid |
Journal of Thoracic Disease | 2015 |
Evidence for microRNA-31 dependent Bim-Bax interaction preceding mitochondrial Bax translocation during radiation-induced apoptosis
A Kumar, S Ghosh, S Chandna |
Scientific Reports | 2015 |
microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance
S Naidu, M Garofalo |
Frontiers in Medicine | 2015 |
Role of deregulated microRNAs in non‑small cell lung cancer progression using fresh‑frozen and formalin‑fixed, paraffin‑embedded samples
Y Wang, J Chen, Z Lin, J Cao, H Huang, Y Jiang, H He, L Yang, N Ren, G Liu |
Oncology Letters | 2015 |
Micro-ribonucleic acid and carcinogenesis: breast cancer as an example
M Al-Khanbashi, M Al-Moundhri |
Oncology Reviews | 2015 |
HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.
Liu P, Zhang H, Liang X, Ma H, Luan F, Wang B, Bai F, Gao L, Ma C |
Oncotarget | 2015 |
A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma
Zhang L, Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zhao XM |
Oncotarget | 2015 |
MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer
Kim HS, Lee KS, Bae HJ, Eun JW, Shen Q, Park SJ, Shin WC, Yang HD, Park M, Park WS, Kang YK, Nam SW |
Oncotarget | 2015 |
MicroRNA Profiles Discriminate among Colon Cancer Metastasis
A Drusco, GJ Nuovo, N Zanesi, GD Leva, F Pichiorri, S Volinia, C Fernandez, A Antenucci, S Costinean, A Bottoni, IA Rosito, CG Liu, A Burch, M Acunzo, Y Pekarsky, H Alder, A Ciardi, CM Croce, A Navarro |
PloS one | 2014 |
LUNG INJURY AND LUNG CANCER CAUSED BY CIGARETTE SMOKE-INDUCED OXIDATIVE STRESS: MOLECULAR MECHANISMS AND THERAPEUTIC OPPORTUNITIES INVOLVING THE CERAMIDE GENERATING MACHINERY AND EGF RECEPTOR
T Goldkorn, S Filosto, S Chung |
Antioxidants & Redox Signaling | 2014 |
MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1
H Wu, Q Liu, T Cai, Y Chen, F Liao, Z Wang |
Diagnostic Pathology | 2014 |
The protein phosphatase 2A regulatory subunit B55α is a modulator of signaling and microRNA expression in acute myeloid leukemia cells
PP Ruvolo, VR Ruvolo, R Jacamo, JK Burks, Z Zeng, SR Duvvuri, L Zhou, Y Qiu, KR Coombes, N Zhang, SY Yoo, R Pan, N Hail, M Konopleva, G Calin, SM Kornblau, M Andreeff |
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research | 2014 |
Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas
SY Luo, KY Sit, AD Sihoe, WS Suen, WK Au, X Tang, ES Ma, WK Chan, II Wistuba, JD Minna, GS Tsao, DC Lam |
Lung Cancer | 2014 |
MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance
R Ottman, C Nguyen, R Lorch, R Chakrabarti |
Molecular Cancer | 2014 |
MicroRNAs-Role in Lung Cancer
M Guz, A Rivero-Müller, E Okoń, A Stenzel-Bembenek, K Polberg, M Słomka, A Stepulak |
Disease Markers | 2014 |
The new concepts on overcoming drug resistance in lung cancer
W Zhang, P Lei, X Dong, C Xu |
Drug design, development and therapy | 2014 |
The potential clinical applications and prospects of microRNAs in lung cancer
Y Gao, F Gao, JL Ma, WZ Sun, LP Song |
OncoTargets and therapy | 2014 |
An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma
X Li, Y Shi, Z Yin, X Xue, B Zhou |
Journal of Translational Medicine | 2014 |
microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
T Mitamura, H Watari, L Wang, H Kanno, M Kitagawa, MK Hassan, T Kimura, M Tanino, H Nishihara, S Tanaka, N Sakuragi |
Molecular Cancer | 2014 |
MiR-31 Dysregulation in Cystic Fibrosis Airways Contributes to Increased Pulmonary Cathepsin S Production
S Weldon, P McNally, DF McAuley, IK Oglesby, CL Wohlford-Lenane, JA Bartlett, CJ Scott, NG McElvaney, CM Greene, PB McCray, CC Taggart |
American journal of respiratory and critical care medicine | 2014 |
Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?
LF Sempere |
Expert Review of Molecular Diagnostics | 2014 |
Prognostic role of microRNA-31 in various cancers: a meta-analysis
S Wang, J Hu, D Zhang, J Li, Q Fei, Y Sun |
Tumor Biology | 2014 |
Induction of cancer-related microRNA expression profiling using excretory-secretory products of Clonorchis sinensis
JH Pak, IK Kim, SM Kim, S Maeng, KJ Song, BK Na, TS Kim |
Parasitology Research | 2014 |
MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2
X Feng, Y Wang, Z Ma, R Yang, S Liang, M Zhang, S Song, S Li, G Liu, D Fan, S Gao |
BMC Cancer | 2014 |
miR-203 Suppresses the Proliferation and Migration and Promotes the Apoptosis of Lung Cancer Cells by Targeting SRC
N Wang, H Liang, Y Zhou, C Wang, S Zhang, Y Pan, Y Wang, X Yan, J Zhang, CY Zhang, K Zen, D Li, X Chen |
PloS one | 2014 |
MicroRNA-21 (miR-21) regulates cellular proliferation, invasion, migration, and apoptosis by targeting PTEN, RECK and Bcl-2 in lung squamous carcinoma, Gejiu City, China
LF Xu, ZP Wu, Y Chen, QS Zhu, S Hamidi, R Navab |
PloS one | 2014 |
Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic
DE Carvajal-Hausdorf, KA Schalper, VM Neumeister, DL Rimm |
Laboratory Investigation | 2014 |
SATB1 and 2 in colorectal cancer
J Brocato, M Costa |
Carcinogenesis | 2014 |
Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component
S Matsumoto, K Nabeshima, M Hamasaki, T Shibuta, T Umemura |
Medical Oncology | 2014 |
MicroRNA in lung cancer
P Joshi |
World Journal of Methodology | 2014 |
EGF Up-Regulates miR-31 through the C/EBPβ Signal Cascade in Oral Carcinoma
WC Lu, SY Kao, CC Yang, HF Tu, CH Wu, KW Chang, SC Lin, B Mari |
PloS one | 2014 |
MicroRNAome genome: A treasure for cancer diagnosis and therapy: miRNA Knowledge for Clinicians
I Berindan-Neagoe, PC Monroig, B Pasculli, GA Calin |
CA A Cancer Journal for Clinicians | 2014 |
Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis.
Wang Y, Wang Q, Zhang N, Ma H, Gu Y, Tang H, Xu Z, Gao Y |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2014 |
Cigarette Smoke Mediates Epigenetic Repression of miR-487b During Pulmonary Carcinogenesis
Sichuan Xi, Hong Xu, Jigui Shan, Yongguang Tao, Julie Hong, Suzanne Inchauste, Mary Zhang, Tricia Kunst, Leandro Mercedes, David Schrump |
Journal of Clinical Investigation | 2013 |
MiRNAs which target CD3 subunits could be potential biomarkers for cancers
FA Alashti, Z Minuchehr |
PloS one | 2013 |
Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties
T Bertero, I Bourget-Ponzio, A Puissant, A Loubat, B Mari, G Meneguzzi, P Auberger, P Barbry, G Ponzio, R Rezzonico |
Cell cycle (Georgetown, Tex.) | 2013 |
MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells
Z Zhong, Z Dong, L Yang, X Chen, Z Gong |
Tumor Biology | 2013 |
Overexpression of SNORD114-3 marks acute promyelocytic leukemia
T Liuksiala, KJ Teittinen, K Granberg, M Heinäniemi, M Annala, M Mäki, M Nykter, O Lohi |
Leukemia | 2013 |
Analysis of microRNAs expressions in chondrosarcoma: MicroRNA EXPRESSION PROFILING OF CHONDROSARCOMA
T Yoshitaka, A Kawai, S Miyaki, K Numoto, K Kikuta, T Ozaki, M Lotz, H Asahara |
Journal of Orthopaedic Research | 2013 |
PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer
S Xiong, Y Zheng, P Jiang, R Liu, X Liu, J Qian, J Gu, L Chang, D Ge, Y Chu |
British Journal of Cancer | 2013 |
Elevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2
MH Yang, J Yu, N Chen, XY Wang, XY Liu, S Wang, YQ Ding |
PloS one | 2013 |
MIR376A is a regulator of starvation-induced autophagy
G Korkmaz, KA Tekirdag, DG Ozturk, A Kosar, OU Sezerman, D Gozuacik |
PloS one | 2013 |
miR-140 suppresses tumor growth and metastasis of non-small cell lung cancer by targeting insulin-like growth factor 1 receptor
Y Yuan, Y Shen, L Xue, H Fan |
PloS one | 2013 |
Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling
A Hergovich |
Cell & Bioscience | 2013 |
Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
S Cufí, R Bonavia, A Vazquez-Martin, C Oliveras-Ferraros, B Corominas-Faja, E Cuyàs, B Martin-Castillo, E Barrajón-Catalán, J Visa, A Segura-Carretero, J Joven, J Bosch-Barrera, V Micol, JA Menendez |
Scientific Reports | 2013 |
miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1
Y Ke, W Zhao, J Xiong, R Cao |
Biochemistry Research International | 2013 |
Evidence for tankyrases as antineoplastic targets in lung cancer
AM Busch, KC Johnson, RV Stan, A Sanglikar, Y Ahmed, E Dmitrovsky, SJ Freemantle |
BMC Cancer | 2013 |
MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1)
D Sun, F Yu, Y Ma, R Zhao, X Chen, J Zhu, CY Zhang, J Chen, J Zhang |
The Journal of biological chemistry | 2013 |
Comparing histone deacetylase inhibitor responses in genetically engineered mouse lung cancer models and a window of opportunity trial in patients with lung cancer
T Ma, F Galimberti, CP Erkmen, V Memoli, F Chinyengetere, L Sempere, JH Beumer, BN Anyang, W Nugent, D Johnstone, GJ Tsongalis, JM Kurie, H Li, J Direnzo, Y Guo, SJ Freemantle, KH Dragnev, E Dmitrovsky |
Molecular cancer therapeutics | 2013 |
MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma
W Meng, Z Ye, R Cui, J Perry, V Dedousi-Huebner, A Huebner, Y Wang, B Li, S Volinia, H Nakanishi, T Kim, SS Suh, LW Ayers, P Ross, CM Croce, A Chakravarti, VX Jin, T Lautenschlaeger |
Clinical cancer research | 2013 |
Handbook of Experimental Pharmacology
T Goldkorn, S Chung, S Filosto |
Handbook of experimental pharmacology | 2013 |
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression
PC Lin, YL Chiu, S Banerjee, K Park, JM Mosquera, E Giannopoulou, P Alves, AK Tewari, MB Gerstein, H Beltran, AM Melnick, O Elemento, F Demichelis, MA Rubin |
Cancer research | 2012 |
MicroRNAs and lung cancers: from pathogenesis to clinical implications
J Qi, D Mu |
Frontiers of Medicine | 2012 |
The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma
HF Tu, CJ Liu, CL Chang, PW Wang, SY Kao, CC Yang, EH Yu, SC Lin, KW Chang |
PloS one | 2012 |
MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer
Y Lu, R Govindan, L Wang, P Liu, B Goodgame, W Wen, A Sezhiyan, J Pfeifer, Y Li, X Hua, Y Wang, P Yang, M You |
Carcinogenesis | 2012 |
Dicer-Dependent Biogenesis of Small RNAs Derived from 7SL RNA
YF Ren, G Li, J Wu, YF Xue, YJ Song, L Lv, XJ Zhang, KF Tang |
PloS one | 2012 |
miR-34 – a microRNA replacement therapy is headed to the clinic
AG Bader |
Frontiers in Genetics | 2012 |
A Unique Combination of Male Germ Cell miRNAs Coordinates Gonocyte Differentiation
SC McIver, SJ Stanger, DM Santarelli, SD Roman, B Nixon, EA McLaughlin |
PloS one | 2012 |
MicroRNAs – Important Molecules in Lung Cancer Research
P Leidinger, A Keller, E Meese |
Frontiers in Genetics | 2012 |
Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer
T Sasahira, M Kurihara, UK Bhawal, N Ueda, T Shimomoto, K Yamamoto, T Kirita, H Kuniyasu |
British Journal of Cancer | 2012 |
Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer
H Alder, C Taccioli, H Chen, Y Jiang, KJ Smalley, P Fadda, HG Ozer, K Huebner, JL Farber, CM Croce, LY Fong |
Carcinogenesis | 2012 |
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis
L Benetatos, E Hatzimichael, E Londin, G Vartholomatos, P Loher, I Rigoutsos, E Briasoulis |
Cellular and Molecular Life Sciences | 2012 |
miRNA-Based Therapeutic Strategies
M Ishida, FM Selaru |
Current Pathobiology Reports | 2012 |
Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations
F Galimberti, AM Busch, F Chinyengetere, T Ma, D Sekula, VA Memoli, KH Dragnev, F Liu, KC Johnson, Y Guo, SJ Freemantle, AS Andrew, P Greninger, DJ Robbins, J Settleman, C Benes, E Dmitrovsky |
International journal of oncology | 2012 |
Evidence for the ubiquitin protease UBP43 as an antineoplastic target
Y Guo, F Chinyengetere, AV Dolinko, A Lopez-Aguiar, Y Lu, F Galimberti, T Ma, Q Feng, D Sekula, SJ Freemantle, AS Andrew, V Memoli, E Dmitrovsky |
Molecular cancer therapeutics | 2012 |
Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression
NP Singh, UP Singh, H Guan, P Nagarkatti, M Nagarkatti |
PloS one | 2012 |
Small regulatory RNAs controlled by genomic imprinting and their contribution to human disease
M Girardot, J Cavaillé, R Feil |
Epigenetics : official journal of the DNA Methylation Society | 2012 |
Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7
Z Zhong, Z Dong, L Yang, X Chen, Z Gong |
Experimental and therapeutic medicine | 2012 |
Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma
S Yamanaka, NR Campbell, F An, SC Kuo, JJ Potter, E Mezey, A Maitra, FM Selaru |
Cell cycle (Georgetown, Tex.) | 2012 |
Role of MicroRNAs in lung disease
M Angulo, E Lecuona, JI Sznajder |
Archivos de Bronconeumología | 2012 |
miR-Sens--a retroviral dual-luciferase reporter to detect microRNA activity in primary cells
E Beillard, SC Ong, A Giannakakis, E Guccione, LA Vardy, PM Voorhoeve |
RNA (New York, N.Y.) | 2012 |
microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review)
YW Jiang, LA Chen |
Molecular medicine reports | 2012 |
MicroRNAs as Biomarkers for Clinical Features of Lung Cancer
R Hubaux |
Journal of Postgenomics: Drug & Biomarker Development | 2012 |
Loss of Rassf1a Synergizes with Deregulated Runx2 Signaling in Tumorigenesis
L van der Weyden, A Papaspyropoulos, G Poulogiannis, AG Rust, M Rashid, DJ Adams, MJ Arends, E O'Neill |
Cancer research | 2012 |
miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer.
Zhong Z, Dong Z, Yang L, Gong Z |
Journal of Cancer Research and Clinical Oncology | 2012 |
Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma.
Asangani IA, Harms PW, Dodson L, Pandhi M, Kunju LP, Maher CA, Fullen DR, Johnson TM, Giordano TJ, Palanisamy N, Chinnaiyan AM |
Oncotarget | 2012 |
Clinical Significance of MicroRNA Expression Profiles and Polymorphisms in Lung Cancer Development and Management
F Megiorni, A Pizzuti, L Frati |
Pathology research international | 2011 |
MicroRNA-31 regulated by the extracellular regulated kinase is involved in vascular smooth muscle cell growth via large tumor suppressor homolog 2
X Liu, Y Cheng, X Chen, J Yang, L Xu, C Zhang |
The Journal of biological chemistry | 2011 |
Regulation of cancer aggressive features in melanoma cells by microRNAs
E Greenberg, L Hershkovitz, O Itzhaki, S Hajdu, Y Nemlich, R Ortenberg, N Gefen, L Edry, S Modai, Y Keisari, MJ Besser, J Schachter, N Shomron, G Markel |
PloS one | 2011 |
A ten-microRNA expression signature predicts survival in glioblastoma
S Srinivasan, IR Patric, K Somasundaram |
PloS one | 2011 |
Characterisation and expression of microRNAs in developing wings of the neotropical butterfly Heliconius melpomene
AK Surridge, S Lopez-Gomollon, S Moxon, LS Maroja, T Rathjen, NJ Nadeau, T Dalmay, CD Jiggins |
BMC Genomics | 2011 |
RNA Interference and Cancer Therapy
Z Wang, DD Rao, N Senzer, J Nemunaitis |
Pharmaceutical Research | 2011 |
Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer
LF Sempere |
Expert Review of Molecular Diagnostics | 2011 |
Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity
P Ru, R Steele, EC Hsueh, RB Ray |
Genes & cancer | 2011 |
An Integrated Analysis of miRNA and mRNA Expressions in Non-Small Cell Lung Cancers
L Ma, Y Huang, W Zhu, S Zhou, J Zhou, F Zeng, X Liu, Y Zhang, J Yu |
PloS one | 2011 |
Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes
G Hanin, H Soreq |
Frontiers in molecular neuroscience | 2011 |
Involvement of MicroRNAs in Lung Cancer Biology and Therapy
X Liu, LF Sempere, Y Guo, M Korc, S Kauppinen, SJ Freemantle, E Dmitrovsky |
Translational research : the journal of laboratory and clinical medicine | 2011 |
Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study
Y Cheng, W Liu, ST Kim, J Sun, L Lu, J Sun, SL Zheng, WB Isaacs, J Xu |
Cancer Genetics | 2011 |
A microRNA downregulated in human cholangiocarcinoma controls cell cycle through multiple targets involved in the G1/S checkpoint
AV Olaru, G Ghiaur, S Yamanaka, D Luvsanjav, F An, I Popescu, S Alexandrescu, S Allen, TM Pawlik, M Torbenson, C Georgiades, LR Roberts, GJ Gores, A Ferguson-Smith, MI Almeida, GA Calin, E Mezey, FM Selaru |
Hepatology | 2011 |
Lung Injury and Cancer
T Goldkorn, S Filosto |
American journal of respiratory cell and molecular biology | 2010 |
Cyclin E Transgenic Mice: Discovery Tools for Lung Cancer Biology, Therapy, and Prevention: Fig. 1
SJ Freemantle, E Dmitrovsky |
Cancer prevention research (Philadelphia, Pa.) | 2010 |
MicroRNA in lung cancer
PY Lin, SL Yu, PC Yang |
British Journal of Cancer | 2010 |
Patterns of microRNA expression in non-human primate cells correlate with neoplastic development in vitro
B Teferedegne, H Murata, M Quiñones, K Peden, AM Lewis |
PloS one | 2010 |
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway
OA Kent, RR Chivukula, M Mullendore, EA Wentzel, G Feldmann, KH Lee, S Liu, SD Leach, A Maitra, JT Mendell |
Genes & development | 2010 |
Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells
CJ Wang, J Stratmann, ZG Zhou, XF Sun |
BMC Cancer | 2010 |
Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells
S Xi, M Yang, Y Tao, H Xu, J Shan, S Inchauste, M Zhang, L Mercedes, JA Hong, M Rao, DS Schrump |
PloS one | 2010 |
The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1
Y Aylon, Y Ofir-Rosenfeld, N Yabuta, E Lapi, H Nojima, X Lu, M Oren |
Genes & development | 2010 |
Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors
LF Sempere, M Preis, T Yezefski, H Ouyang, AA Suriawinata, A Silahtaroglu, JR Conejo-Garcia, S Kauppinen, W Wells, M Korc |
Clinical cancer research | 2010 |
[MicroRNAs as therapeutic targets for lung cancer]
William C S CHO |
Zhongguo fei ai za zhi = Chinese journal of lung cancer | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |